Tandem Diabetes Care completed the acquisition of AMF Medical for $216m.

Tandem Diabetes Care, an American medical device manufacturer based in San Diego, completed the acquisition of AMF Medical, a medical equipment manufacturer in Saint-Sulpice, Switzerland, for $216m. "This acquisition supports our commitment to drive growth through innovation, as AMF Medical has novel technology and a shared passion for creating easy-to-use solutions to improve the lives of people with diabetes. Our portfolio approach to diabetes care is designed to bring the benefits of advanced insulin pump therapy to more people worldwide, utilize our expertise in automated insulin delivery technology and data management, and leverage our commercial infrastructure to create shareholder value," John Sheridan, Tandem Diabetes Care President and CEO.